Hyperthyroidism or hypothyroidism are commonly associated with altered blood pressure (BP). Restriction of sodium in the diet produces a decrease in BP in some individuals. It is also well known that hormones other than thyroid affect BP. The present study was designed to evaluate the influence of a low sodium diet on BP in patients with hyperthyroidism or hypothyroidism during therapy. The occurrence of salt-sensitive or salt-nonsensitive BP was compared with hormonal levels (plasma renin activity, aldosterone, atrial natriuretic peptide, and arginine vasopressin).
I
mpaired function of the thyroid gland is commonly associated with hypertension. [1] [2] [3] [4] [5] [6] It is estimated that systolic hypertension occurs in one-third of the patients with hyperthyroidism, and about 20% of the patients with hypothyroidism suffer from systolic and diastolic hypertension. 2 Diastolic hypertension was found in 30% of the older hypothyroid patients (aged 50 to 70 years). 5 Hypertension in hyperthyroid patients is associated with hyperkinetic circulation (ie, an increased cardiac output and a decreased resistance in the peripheral vessels). 2 An increase in the peripheral vessel resistance was found in the patients with hypothyroidism and this phenomenon may be the result of water and sodium retention. 2, 3 On the other hand, impaired thyroid function is accompanied by changes in other hormone levels including hemodynamic regulating hormones and those responsible for constriction of the blood vessels and volume of the circulating blood. Changes of plasma renin activity, plasma level of angiotensin and aldosterone, [7] [8] [9] arginine vasopressin, 10 -12 and atrial natriuretic peptide [13] [14] [15] were reported. It has been found that the blood pressure (BP) response to decreased sodium content in the diet differs with the individual. This phenomenon is caused by the different activity of the neurohormones, especially those acting on the vascular bed. 16 -22 The present study was designed to evaluate the effect of a short-term application of a low sodium diet on BP in patients with hyperthyroidism or hypothyroidism with simultaneous determination of plasma renin activity, aldosterone, arginine vasopressin, and atrial natriuretic peptide levels.
Methods

Subjects and Procedures
Seventy-five patients (71 women, 4 men) with hyperthyroidism, 31 patients (26 women, 5 men) with hypothyroid-ism, and 37 healthy individuals (35 women, 2 men) were investigated. All investigated subjects were aged 18 to 50 years, the mean (Ϯ SEM) age of the hyperthyroid, hypothyroid, and control groups was 33.4 Ϯ 1.0 years, 38.1 Ϯ 1.5 years, and 32.5 Ϯ 1.4 years, respectively. Patients with a previous diagnosis of arterial hypertension, circulatory failure, cardiac defects, disorder of the kidneys or liver, or other thyroid-associated endocrine and metabolic diseases and inflammatory states were excluded from the study. Pregnant women were also excluded from the study. All investigated subjects had not taken any medication at least 2 weeks before the study.
The study was approved by the ethical committee and all investigated subjects gave an informed consent for participation.
Hyperthyroidism was caused by Graves' disease in 61 subjects and by nodular goiter in 14 patients. Diagnosis of hyperthyroidism was based on clinical picture and serum level of total thyroxine, total triiodothyronine, free thyroxine, free triiodothyronine, and thyrotropic hormone. Patients with hyperthyroidism were investigated three times, before initiation of the medication, after 2 weeks of the treatment, and after attainment of the euthyroid state. Patients with hyperthyroidism were treated with thiamazole (1-methylo-2-imidazolothiol; Polfa, Poland). The drug was taken as a daily dose of 45 to 60 mg (mean dose, 54.5 mg) for at least 2 weeks, and subsequently the dose was reduced in relation to the decrease of symptoms of hyperthyroidism. The management was continued with the daily dose of 5 to 10 mg of thiamazole. The mean period of the treatment to attain the euthyroid state was 9 months.
Primary hypothyroidism was diagnosed based on clinical picture and results of the hormone determination (the same is true for patients with hyperthyroidism). The patients with hypothyroidism were investigated twice, before initiation of the treatment and after normalization of the thyreometabolic state. Patients were treated with L-thyroxine (Eltroxin, Glaxo, London, UK) in a daily dose of 100 to 300 g (mean, 198 g) adjusted to clinical and hormonal state. The mean period of treatment was 12 months. The control group was investigated only once.
In all investigated subjects, BP and hormone levels were determined. Blood pressure and heart rate measurements were done between 7:30 and 8:00 AM, after an overnight fast, and after 20 min of resting in the sited position. The measurements were taken three times at an interval of a few minutes. Measurements were done with a mercury manometer according to the method of Korotkoff on the right arm. The precision of pressure determination was 2 mm Hg. The fifth phase of Korotkoff for diastolic pressure measurement was used. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were determined. Mean arterial pressure (MAP) was calculated according to the formula MAP ϭ 1/3 (SBP Ϫ DBP) ϩ DBP. The subjects were given a normal sodium diet (120 mmol of sodium, 70 mmol of potassium) for 3 days. After eating the normal sodium diet, the mea- 
Values are means Ϯ SEM. Statistical significance of the differences as compared with controls: * P Ͻ .05; † P Ͻ .01; ‡ P Ͻ .001. Statistical significance of the differences as compared with the same subjects under a normal sodium diet: § P Ͻ .05; P Ͻ .01; ¶ P Ͻ .001. 
Values are means Ϯ SEM. Statistical significance of the differences as compared with controls: * P Ͻ .05; † P Ͻ .01; ‡ P Ͻ .001. Statistical significance of the differences as compared with the same subjects under a normal sodium diet: § P Ͻ .05; P Ͻ .01; ¶ P Ͻ .001.
surements were taken and the subjects ate a low sodium diet (10 mmol of sodium, 70 mmol of potassium) for another 3 days. After application of the low sodium diet, all measurements were repeated. The efficacy of the 3-day period on a low sodium diet and compliance of the patients was evaluated with urine sodium measurement. These measurements were taken only in the patient groups. The investigated subjects were divided into sodium-sensitive and sodium-resistant groups based on the MAP. Criterion of sodium sensitivity, as reported by Sullivan and Ratts
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(ie, lowering of MAP by more than 5% after application of a low sodium diet as compared with MAP on a normal sodium diet) was used in the study. Blood for determination of hormone levels and sodium and potassium levels were taken after 3 days on a normal sodium diet. The blood was sampled after 8 h of laying in bed and was taken in the horizontal position. The second blood sample was obtained after 3 days on a low sodium diet and 3 h in the upright position. The patients did not smoke, drink coffee and black tea for at least 15 h before blood sampling.
Laboratory Measurements
Plasma renin activity, aldosterone and arginine vasopressin levels were determined using radioimmune methods and kits commercially available from the Institute for Research, Production and Application of Radioisotopes, Prague (Czech Republic). Atrial natriuretic peptide, free thyroxine, and free triiodothyronine were measured using the kits obtained from Amersham (London, UK). Thyroxine and triiodothyronine were determined with the radioimmune method using the kits from OBRI (Ś wierk, Poland). Serum thyrotropic hormone level was measured with the kit of Farmos Diagnostica (Helsinki, Finland). Serum sodium and potassium levels and hematocrit were determined with routine methods. Percentage of the plasma volume change was calculated according to the following formula 23 : ⌬PV% ϭ [100/(100 Ϫ Ht 1 )] ϫ [100 (Ht 1 Ϫ Ht 2 )]/Ht 2 , where ⌬PV% is percentage of plasma volume change; Ht 1 , hematocrit determined in basal condition (normal sodium diet); and Ht 2 , hematocrit determined after application of a low sodium diet. Body mass index (BMI) was calculated according to the formula: BMI ϭ body mass (in kilograms)/(height (in meters squared).
Statistical Analysis
Variance analysis was done with the Fisher test. When variances were equal, the statistical significance of the differences was determined with the Student's t test. The Satterthwaite's test was used for determination of differences between means, when variances were unequal. The investigated groups with sodium-sensitive and sodiumresistant pressure were compared with the nonparametric 2 test. Table 1 summarized thyroid hormones and thyrotropic hormone measurements in the investigated groups. Table 2 shows the results of SBP, DBP, and heart rate determination, as well as calculated MAP in individuals receiving a normal sodium or a low sodium diet. Elevated SBP was found both in the patients with hyperthyroidism and those with hypothyroidism. Some decrease in SBP was in shown patients with hyperthyroidism, although SBP after attainment of the euthyroid state was still higher than in controls. Diastolic blood pressure was similar to that of the healthy subjects after the treatment. Two weeks of treatment for hyperthyroidism was sufficient for some hormonal normalization (Table 1) , but had no effect on DBP (Table 2 ). There was no difference in SBP in the hypothyroid patients before and after the treatment. Application of a low sodium diet resulted in some decrease in SBP, DBP, and MAP in untreated hypothyroid patients only.
Results
The patients with hypothyroidism before the initiation of therapy had higher DBP compared with controls. Application of a low sodium diet caused a decrease in DBP only in the untreated patients with hypothyroidism. Mean arterial pressure was higher only in the patients Statistical significance of the differences as compared with the controls: * P Ͻ .05.
with hypothyroidism. Application of a low sodium diet resulted in a significant decrease in MAP. As expected, heart rate was higher in patients with hyperthyroidism before the treatment than in healthy individuals and patients with hypothyroidism had a lower heart rate than controls. Application of a low sodium diet caused an increase in the heart rate in almost all investigated subjects. Table 3 summarized results of determination of serum sodium and potassium levels, hematocrit, and a calculated change of plasma volume. There was no difference in serum sodium level between the groups of patients and application of a low sodium diet did not result in alterations in serum sodium levels. The serum potassium level was also similar in all investigated groups under basal conditions. Application of a low sodium diet caused an increase in serum potassium level in all groups of the patients. There was no significant change of serum potassium level in the controls after application of a low sodium diet. A slight decrease in hematocrit was found in hyperthyroid and hypothyroid patients before treatment as compared with controls. Application of a low sodium diet caused an increase in hematocrit only in the hyperthyroid patients. This increase was found both before the treatment and after the attainment of the euthyroid state. Changes of plasma volume induced by a low sodium diet were expressed as a percentage of the initial volume and were similar in all investigated groups. There was a decrease in the plasma volume in patients with hyperthyroidism, but there was an increase the plasma volume in those patients with hypothyroidism. Table 4 summarized the incidence of salt-sensitive BP in the investigated groups. It was found that about onefourth of healthy individuals had salt-sensitive BP. Similar values were found in the patients with hyperthyroidism. There was no change in the incidence of salt-sensitive BP in patients with hyperthyroidism during the therapy. A high incidence of salt-sensitive BP was shown in hypothyroid patients. Some decrease in incidence was found in hypothyroid patients after the treatment and there was no significant difference in incidence between the controls and hypothyroid patients after attainment of the euthyroid state (Table 4) .
Age, BMI, and MAP in groups of the patients with salt-sensitive and salt-resistant BP were shown in Table 5 . The age of the patients of all groups with salt-sensitive or salt-resistant BP was similar, except for healthy individuals; in the group of healthy individuals with salt-resistant BP, the mean age was lower than in those with saltsensitive BP (Table 5 ). There was no difference in BMI between the groups of the patients. Body mass index was lower in healthy individuals with salt-resistant BP as compared with those with salt-sensitive BP. Mean arterial pressure was lower in all groups of the patients and controls with salt-resistant BP, except in patients with hypothyroidism after attainment of the euthyroid state. Table 6 shows the determination of hormones regulat- Table 5 . Age, body mass index, and mean arterial pressure in patients with hyperthyroidism or hypothyroidism and controls divided into groups of those with salt-sensitive or salt-nonsensitive blood pressure Values are means Ϯ SEM. Statistical significance of the differences as compared with the subjects with salt-sensitive blood pressure: * P Ͻ .05; † P Ͻ .01.
ing BP. There was no difference between groups with salt-sensitive and salt-resistant BP, either with the normal sodium diet or the low sodium diet. The only difference was found in healthy individuals. Application of a low sodium diet was associated with elevated serum aldosterone level in these subjects. Application of a low sodium diet in the patients with hypothyroidism before the treatment led to a slight increase in plasma renin activity in those with salt-sensitive BP compared to those with saltresistant BP. An increase in plasma renin activity in hyperthyroid patients after sodium restriction was higher than in controls (P Ͻ .001), and in untreated hypothyroid patients (P Ͻ .001). Plasma renin activity was also lower in hypothyroid patients on a normal sodium diet as compared with controls (P Ͻ .01). Changes in plasma renin activity, which negatively correlated with a decrease in DBP (r ϭ Ϫ0.49; P Ͻ .01), SBP (r ϭ Ϫ0.48; P Ͻ .01), and MAP (r ϭ Ϫ0.48; P Ͻ .01), were shown in these patients.
Discussion
We were unable to find any report in the literature on salt sensitivity in BP in patients with hyperthyroidism or hypothyroidism. In this study, there was a significantly higher incidence of salt sensitivity in patients with hypothyroidism before treatment. It suggests that a deficiency in thyroid hormones increases the pressure response to salt restriction. The mechanism remains unclear. It is possible that in patients with hypothyroidism, the vascular wall is thicker and surrounding tissues are edematosus as a result of sodium retention in extravascular space. 24 -26 Bing et al 3 have suggested that this mechanism is responsible for increased BP in patients with hypothyroidism. Restriction of diet sodium may lead to a decrease in sodium content in tissues and subsequently in a decrease in BP. Salt sensitivity of BP is suggested to be related to the activity of the renin-angiotensin-aldosterone system. It was been reported that plasma renin activity and serum aldosterone level are lower in individuals with normal or borderline salt-sensitive BP as compared with the individuals with salt-resistant BP. 20 -22 Campese et al 16 investigated patients with essential hypertension and they showed that the enhanced reactivity of vascular bed to angiotensin II is higher in patients with salt-resistant BP than in those with salt-sensitive BP. These phenomena may be caused by upregulation of vascular receptors of angiotensin II because in these patients the activity of the plasma renin is usually lower than in patients with saltresistant BP. In the present study, we have shown an increase in plasma renin activity only in untreated hypothyroid patients with salt-resistant hypertension. It is difficult to conclude that the observed high incidence of salt sensitivity of BP in the patients with hypothyroidism is the result of alterations in plasma renin activity.
There was no difference of serum atrial natriuretic peptide and arginine vasopressin levels between the patients with salt-sensitive and salt-resistant BP, regardless of the thyroid state. It suggests that those hormones do not play a significant role in BP alterations in the patients with thyroid dysfunctions.
It has been suggested that the response of BP to sodium restriction is related to the activity of the sympathetic system. Feldman 18 and Naslund et al 19 reported that application of a low sodium diet caused an increased sensitivity of the ␤-adrenergic receptors of the blood vessels. This increase could be associated with vasodilatation. It has been suggested that the intracellular content of sodium affects the adrenergic receptor state. 19 Moreover, Egan et al 17 reported that blood level of noradrenaline was lower in patients with salt-sensitive BP than in those with saltresistant BP. Additional studies are needed on the responsibility of the adrenergic receptor under conditions of sodium restriction in patients with excess or depletion of thyroid hormones.
Vasoactive properties of triiodothyronine were investigated in primary cultures of aortic endothelial and vascular smooth muscle cells. Triiodothyronine was found to bind to the specific binding sites on plasma membranes of the vascular smooth muscle cells. This binding is associated with vascular relaxation and this phenomenon is a direct action of triiodothyronine on the cells. Triiodothyronineinduced relaxation was shown to be unrelated to nitric oxide production and release, cellular cGMP content, or phosphorylation of the light chain of myosin. 27 The findings of Ojamaa et al 27 elucidate the possible mechanism of increased vascular resistance in patients with hypothyroidism and this may be a possible explanation for the higher response to sodium restriction.
It is concluded that different mechanisms are responsible for BP elevation in patients with hyperthyroidism or hypothyroidism. It is difficult to conclude that plasma renin activity is responsible for the high incidence of salt sensitivity in hypothyroid patients.
